RU2018107052A3 - - Google Patents

Download PDF

Info

Publication number
RU2018107052A3
RU2018107052A3 RU2018107052A RU2018107052A RU2018107052A3 RU 2018107052 A3 RU2018107052 A3 RU 2018107052A3 RU 2018107052 A RU2018107052 A RU 2018107052A RU 2018107052 A RU2018107052 A RU 2018107052A RU 2018107052 A3 RU2018107052 A3 RU 2018107052A3
Authority
RU
Russia
Application number
RU2018107052A
Other languages
Russian (ru)
Other versions
RU2018107052A (en
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of RU2018107052A3 publication Critical patent/RU2018107052A3/ru
Publication of RU2018107052A publication Critical patent/RU2018107052A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/88Post-polymerisation treatment
    • C08G63/90Purification; Drying
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • A61K31/122Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/66Polyesters containing oxygen in the form of ether groups
    • C08G63/664Polyesters containing oxygen in the form of ether groups derived from hydroxy carboxylic acids
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/78Preparation processes
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/78Preparation processes
    • C08G63/82Preparation processes characterised by the catalyst used
    • C08G63/823Preparation processes characterised by the catalyst used for the preparation of polylactones or polylactides
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G63/00Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
    • C08G63/78Preparation processes
    • C08G63/82Preparation processes characterised by the catalyst used
    • C08G63/85Germanium, tin, lead, arsenic, antimony, bismuth, titanium, zirconium, hafnium, vanadium, niobium, tantalum, or compounds thereof
RU2018107052A 2015-07-28 2016-07-28 PHARMACEUTICAL COMPOSITION WITH IMPROVED STABILITY AT STORAGE AND METHOD FOR PRODUCING IT RU2018107052A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR20150106626 2015-07-28
KR10-2015-0106626 2015-07-28
PCT/KR2016/008265 WO2017018816A1 (en) 2015-07-28 2016-07-28 Pharmaceutical composition with improved storage stability and method for preparing the same

Publications (2)

Publication Number Publication Date
RU2018107052A3 true RU2018107052A3 (en) 2019-08-28
RU2018107052A RU2018107052A (en) 2019-08-28

Family

ID=57884841

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2018107052A RU2018107052A (en) 2015-07-28 2016-07-28 PHARMACEUTICAL COMPOSITION WITH IMPROVED STABILITY AT STORAGE AND METHOD FOR PRODUCING IT

Country Status (13)

Country Link
EP (1) EP3328434A4 (en)
JP (1) JP6605706B2 (en)
KR (1) KR101748191B1 (en)
CN (2) CN111574702A (en)
AU (1) AU2016299544A1 (en)
BR (1) BR112018001736A2 (en)
CA (1) CA2993920A1 (en)
HK (1) HK1249439A1 (en)
IL (1) IL257185A (en)
MX (1) MX2018001219A (en)
RU (1) RU2018107052A (en)
WO (1) WO2017018816A1 (en)
ZA (1) ZA201801189B (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020211584A1 (en) * 2019-04-19 2020-10-22 海正生物制药有限公司 Detection method for poloxamer 188 in composition
KR20220082975A (en) * 2020-12-10 2022-06-20 주식회사 삼양홀딩스 Method for preparing polymeric micelle nanoparticle capable of reducing reconstitution time

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0180334B1 (en) 1995-09-21 1999-03-20 김윤 Drug messenger using el-2l-2 micelle and method for sealing drug to it
KR100360827B1 (en) * 1999-08-14 2002-11-18 주식회사 삼양사 Polymeric composition for solubilizing poorly water soluble drugs and process for the preparation thereof
KR100412227B1 (en) 2000-05-12 2003-12-24 주식회사 삼양사 Method for the preparation of polymeric micelles via phase separation of block copolymer
US7217770B2 (en) * 2000-05-17 2007-05-15 Samyang Corporation Stable polymeric micelle-type drug composition and method for the preparation thereof
NZ532198A (en) * 2001-10-18 2006-03-31 Samyang Corp Polymeric micelle composition of an amphiphilic block copolymer and a polylactic acid derivative
KR101024742B1 (en) * 2007-12-31 2011-03-24 주식회사 삼양사 Amphiphilic Block Copolymer Micelle Composition Containing Taxane and Manufacturing Process of The Same
US8853351B2 (en) * 2007-12-31 2014-10-07 Samyang Biopharmaceuticals Corporation Highly pure amphiphilic copolymer comprising hydrophobic block from alpha-hydroxy acid and process for the preparation thereof
US9801818B2 (en) * 2007-12-31 2017-10-31 Samyang Biopharmaceuticals Corporation Method for stabilizing amphiphilic block copolymer micelle composition containing poorly water-soluble drug
EP2201935B1 (en) * 2008-12-26 2020-07-08 Samyang Biopharmaceuticals Corporation Polymeric micelle composition containing a poorly soluble drug and preparation method of the same
CN101444510B (en) 2008-12-31 2011-03-09 南京卡文迪许生物工程技术有限公司 Pharmaceutical preparation containing voriconazole and preparation method thereof
CN104758256B (en) * 2014-02-14 2016-05-04 苏州海特比奥生物技术有限公司 A kind of docetaxel nanometer polymer micelle lyophilized formulations and preparation method thereof

Also Published As

Publication number Publication date
WO2017018816A1 (en) 2017-02-02
EP3328434A4 (en) 2019-03-13
JP2018521094A (en) 2018-08-02
MX2018001219A (en) 2018-04-24
CN111574702A (en) 2020-08-25
HK1249439A1 (en) 2018-11-02
IL257185A (en) 2018-03-29
ZA201801189B (en) 2019-01-30
CA2993920A1 (en) 2017-02-02
RU2018107052A (en) 2019-08-28
BR112018001736A2 (en) 2018-09-11
KR101748191B1 (en) 2017-06-19
CN106559983A (en) 2017-04-05
JP6605706B2 (en) 2019-11-13
KR20170015198A (en) 2017-02-08
EP3328434A1 (en) 2018-06-06
AU2016299544A1 (en) 2018-03-08

Similar Documents

Publication Publication Date Title
RU2018107057A3 (en)
RU2018107052A3 (en)
BE2015C047I2 (en)
BE2015C044I2 (en)
BR9911304B1 (en)
BR0008132B1 (en)
BR0009349B1 (en)
BR0009373B1 (en)
CN303170447S (en)
BR0007468B1 (en)
BR0003208B1 (en)
BR0007487B1 (en)
CN303170358S (en)
CN303154788S (en)
BR0009649B1 (en)
CN303150929S (en)
BR0003189B1 (en)
BR0009717B1 (en)
CN303124545S (en)
BR0009757B1 (en)
BR0007672B1 (en)
BR0005085B1 (en)
BR0007688B1 (en)
BR0007747B1 (en)
CN303123227S (en)